Theravance Biopharma to Participate in an Upcoming Investor Conference Feb 20, 2025 06:00AM
Theravance Biopharma (TBPH) PT Lowered to $9 at TD Cowen Aug 6, 2024 09:11AM
TD Cowen Reiterates Hold Rating on Theravance Biopharma (TBPH) May 24, 2024 08:54AM
Theravance Biopharma to Participate in an Upcoming Investor Conference Feb 22, 2024 06:00AM
Theravance Biopharma to Participate in an Upcoming Investor Conference Mar 2, 2023 06:00AM


Feb 22, 2022 06:00AM Theravance Biopharma to Participate in an Upcoming Investor Conference
Sep 15, 2021 03:55PM Theravance Biopharma (TBPH) PT Lowered to $8 at Cowen
Aug 24, 2021 05:56AM UPDATE: Cowen Downgrades Theravance Biopharma (TBPH) to Market Perform
Feb 10, 2021 06:00AM Theravance Biopharma to Participate in Upcoming Investor Conferences
May 13, 2020 05:46AM Cowen Starts Theravance Biopharma (TBPH) at Outperform
Mar 2, 2020 07:00AM Theravance Biopharma Announces Closing of Private Placement of $400 Million Non-Recourse Notes
Feb 18, 2020 07:00AM Theravance Biopharma Announces Presentations at Upcoming Investor Conferences
Feb 12, 2020 05:52AM Theravance Biopharma (TBPH) Prices 5.5M Share Common Offering at $27/Sh
Feb 11, 2020 11:05PM Theravance Biopharma Announces Pricing of Public Offering of Ordinary Shares
Feb 10, 2020 04:25PM Theravance Biopharma (TBPH) to Offer $150M in Common Stock
Feb 10, 2020 04:01PM Theravance Biopharma Announces Proposed Public Offering of Ordinary Shares
Mar 3, 2016 04:30PM Theravance Biopharma to Present at Cowen and Company 36th Annual Health Care Conference